Pfizer-BioNTech to commence late stage study of COVID-19 vaccine candidate
The study is expected to include about 120 sites globally and up to 30,000 participants
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
BioNTech
US sets global benchmark for COVID-19 vaccine price at around the cost of a flu shot
Unlike other vaccine deals signed by the government, Pfizer and BioNTech will not collect a payment until their vaccine proves to…
US to pay Pfizer, BioNTech $1.95 billion for COVID-19 vaccine
The contract for 100 million doses of the vaccine amounts to a $39 price tag for what is likely to be a two-dose course of…
Brazil approves human trials for third COVID-19 vaccine in collaboration with Pfizer, BioNTech
The country is also scrambling to secure supplies of potential vaccines, in case they are proven successful
China gives the go-ahead for human trials of BioNTech’s COVID vaccine candidate
The potential vaccine is one of the two most advanced candidates that BioNTech is working on with its partner Pfizer and they…
Pfizer, BioNTech’s coronavirus vaccine candidates get US FDA’s ‘fast track’…
The market is “desperate to latch onto any positive developments in the vaccine field,” JP Morgan analyst Cory Kasimov said in a…
Pfizer, BioNTech post positive data from study of COVID-19 vaccine candidate
If studies are successful and mRNA-based vaccine candidate receives regulatory approval, companies expect to manufacture up to 100…
European Investment Bank to provide BioNTech with up to €100 million in debt financing for COVID-19…
mRNA vaccines consist of genetic material, called messenger RNA, that provides instructions for a human cell to make a target…
Germany approves trials of COVID-19 vaccine candidate
The trial, only the fourth worldwide of a vaccine targeting the virus, will be initially conducted on 200 healthy people, with…
Pfizer, BioNTech to co-develop potential coronavirus vaccine
Pfizer already collaborates with BioNTech to develop mRNA-based vaccines for influenza